We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for delandistrogene moxeparvovec (Roche Products Pty Ltd)
Active ingredients
delandistrogene moxeparvovec
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Intravenous infusion
Indication
Treatment of Duchenne muscular dystrophy
Therapeutic area
Musculoskeletal